SLR Investment Corp announced its financial results for Q1 2026, reporting net investment income of $17.9 million or $0.33 per share, with a net asset value (NAV) of $18.16 per share, slightly down from $18.26 at year-end 2025. The company declared a quarterly dividend of $0.31 per share payable in June 2026. Despite geopolitical and market uncertainties, SLR maintained a 100% performing portfolio and reduced its performance-based incentive fee to align with shareholders. The company remains cautious but optimistic about rebuilding its portfolio and pursuing growth initiatives in specialty finance sectors throughout the year.
The 32nd Global Family Office Investment Summit in Lake Como gathered over 200 family office leaders, investors, and entrepreneurs from 27 countries to discuss emerging trends in AI, private equity, healthcare innovation, and global investment opport...
Bath & Body Works introduced Fruit Fusion, a new body care franchise featuring fruit-inspired scents and hydrating formulas, available in the U.S. and Canada starting July 6, 2026. Actress Hilary Duff serves as the brand ambassador and creative partn...
Prestige Consumer Healthcare completed the acquisition of Australian therapeutic skin care company LaCorium Health for approximately $150 million in cash on July 1, 2026. LaCorium, known for brands like Dermal Therapy and Flexitol, generates about $4...
GuideAI Health Corp. has appointed Dr. James F. Benenati, a leading interventional radiologist, to its Advisory Board following FDA 510(k) clearance of its AI software, VascularAssist Occlusion Triage (VAOT). VAOT is designed to help radiologists pri...
Diginex Limited has agreed with Resulticks to extend the deadline for their acquisition deal to July 31, 2026, after securing firm funding intent from private investors. The company does not plan to seek public funding and expects this to be the fina...
